CD4 and melanoma: Consistent with previous analyses, we found that inhibition of SPHK1 activity significantly diminished the levels of CD4+CD25+FoxP3+ regulatory T cells (Tregs) and Gr-1+CD11b+ myeloid-derived suppressor cells (MDSCs) in melanoma (Supplementary Fig. 2h–k).